Mark Trolice/LinkedIn
Sep 13, 2026, 14:17
Mark Trolice: Could AI-Discovered Drugs Lead to No-Injection IVF?
Mark Trolice, Director of The IVF Center, shared on LinkedIn:
“No Injection IVF?
EMD Serono, has acquired two fertility programs developed by PostEra using AI-assisted drug discovery:
- small-molecule FSH-receptor agonists for ovarian stimulation
- LH/CG-receptor agonists aimed at ovulation triggering and male infertility.
EMD Serono assumes development and potential worldwide commercialization; the programs remain preclinical, so this is a technology bet rather than an imminent clinical replacement for gonadotropins.
Stay tuned!”
Stay informed with the latest updates in fertility and reproductive medicine on Fertility News.
-
Sep 13, 2026, 15:11Sachintha Alwis: From Impaired Sperm Motility to Microrobotics
-
Sep 13, 2026, 15:08Laurence Orbuch: Before Endometriosis Surgery, Ask…
-
Sep 13, 2026, 15:05Ademola Ayodele: IUI, IVF or Egg Freezing – Which One Is Right for You?
-
Sep 13, 2026, 14:59Fiona Pathiraja-Møller: Tennis Players No Longer Have to Choose Between Career and Family
-
Sep 13, 2026, 14:571-Day Virtual Experience for People Impacted by PMOS – PCOS Awareness Association
-
Sep 13, 2026, 14:53Ozor Victor: Behind Every Embryo Is a Story of Science, Precision, and Hope
-
Sep 13, 2026, 14:50Diana Kayal: What They Don’t Tell You About IVF
-
Sep 13, 2026, 14:44Vikram Sinai Talaulikar: A Heartfelt Thank You to All Who Donated and Supported “Menopause and Cancer”
-
Sep 13, 2026, 14:41Nicole McPherson: Changing IVF Practices Is Hard – Integration Needs to Be Easy